Replimune Group, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US76029N1063
USD
10.53
0.53 (5.3%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryReplimune Group, Inc. VS Pharmaceuticals & Biotechnology
 
1D
5.3%
0.3%
1W
4.67%
0.54%
1M
13.16%
-0.03%
YTD
-13.05%
16.46%
1Y
-19.86%
13.22%
3Y
-48.18%
68.23%
5Y
-76.67%
86.81%
10Y
-76.67%
234.19%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
78.63%
0%
78.63%
6 Months
9.35%
0%
9.35%
1 Year
-19.86%
0%
-19.86%
2 Years
-10.08%
0%
-10.08%
3 Years
-48.18%
0%
-48.18%
4 Years
-61.93%
0%
-61.93%
5 Years
-76.67%
0%
-76.67%

Replimune Group, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary